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Mammals possess a remarkable ability to maintain and defend a constant internal milieu against diverse
environmental threats. Unsurprisingly, the two systems tasked with these duties, metabolism and immunity,
have evolved to share a common modular architecture that allows extensive bidirectional communication
and coordination. Indeed, recent observations have highlighted numerous functionally critical immune
regulatory modules located within diverse metabolic circuits. In this review, we discuss the architectural
commonality between immunity andmetabolism and highlight how these two primordially disparate systems
leverage shared regulatory axes to coordinate metabolic physiology under conditions of normality and
chronic overnutrition. Such an integrated perspective both advances our understanding of basic physiology
and highlights potential opportunities for therapeutic intervention in metabolic dysfunction.Introduction
Life in the inconstant world is fraught with challenges. Reproduc-
tion, growth, and even simple homeostasis all demand reliable
and uninterrupted maintenance while the environment around
us is in constant, unpredictable flux. Body temperature, for
example, must be maintained within narrow limits while ambient
temperatures vary wildly. Nutrients must bemaintained constant
and in appropriate proportion while food availability (to say
nothing of composition) can unpredictably vary from feast to
famine. Survival is predicated on the maintenance of a stable,
Goldilocks-like internal milieu buffered from an inhospitable
external environment. Mammals, however, are not unique in
our preference for stable, nutrient-laden climes; theworld around
us teemswith life—bacteria, viruses, fungi, and even other meta-
zoans—all with similar preferences and many poised to invade
and coopt our resources for their own priorities. Indeed, the
disproportionate evolutionary success enjoyed by mammals is
attributable largely to their ability to successfully maintain and
defend this particular internal milieu (Wilson et al., 2012).
It is unsurprising that, shaped by millennia under these con-
current pressures, evolution has reached for common solutions
when confronting these disparate necessities. Indeed, the
systems taskedwithmaintaining and defending the internal envi-
ronment, such asmetabolism and immunity, organize responses
along similar, modular lines, allowing our relatively limited
genetic diversity to match the far greater diversity of unique envi-
ronmental situations (Boehm, 2012). Moreover, these responses
both match short-term environmental fluctuations and integrate
them over time to detect and adapt to long-term patterns (e.g.,
changing seasons or recurring pathogens) (Humphries et al.,
2003). Importantly, these commonalities of architecture (both
employ the same modular architecture), challenges (both
confront ever-varying threats), and biological goals (both strive
to preserve the internal milieu) weld together these responses
into the cooperative, collaborative, and coherent physiology
necessary for complex life.644 Immunity 38, April 18, 2013 ª2013 Elsevier Inc.In this review, we discuss the general architecture of canonical
immune and metabolic responses with special emphasis on the
modular organization of individual regulatory circuits. These
same architectural principles apply to immune-mediated meta-
bolic control and allow us to understand how these circuits
function and interact with more traditional regulatory modalities
to preserve short-term stability and adapt to long-term environ-
mental changes. Such a conceptual framework provides the
context in which one can systematically organize the existing
knowledge of immune metabolic control, infer yet undescribed
regulatory components, and better target potential therapeutic
interventions.
Architectural Principles of Immunity
The mammalian immune system is remarkably complex; how-
ever, each individual function—and indeed the system as a
whole—is patterned on the same, highly stereotyped modular
architecture (Figure 1). In each discrete component, modules
operate in directional series to transform specific inputs into
reproducible outputs. Although this organization is common to
most biological systems, immune responses follow a further
stereotyped organization, most often cued to primordial host-
defense functions and purposed to defend a static baseline of
sterility (Medzhitov, 2008). As such, system inputs (stimuli) are
generally indicators of a break in that sterility (such as path-
ogen-derived molecules) or at least the potential there for (self-
derived danger signals, such as necrotic cell debris). Such
stimuli activate specific sensor modules (e.g., Toll-like receptors
[TLRs], nucleotide-binding oligomerization domain [NOD]-like
receptors, RIG-I-like receptors [RLRs], etc.), triggering a
response (Elinav et al., 2011; Kawai and Akira, 2011; Lamkanfi
and Dixit, 2012). The exact character of this initial response is
varied (kinase activation, oligomerization, peptide release,
etc.); however, all result in the transduction of the incident stim-
ulus into a transmissible mediator (typified by cytokines and
chemokines but also including diffusible small molecules like
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Figure 1. Immunity and Metabolism Share a Common Modular Architecture
In most biological systems, sensor modules transduce stimuli into downstreammediators that, in turn, activate effector responses, which generally feed back to
eliminate the incident stimulus and return the system to its baseline condition. Despite their disparate primordial functions, canonical host defense andmetabolic
circuits are both organized in this manner. Importantly, this shared architecture allows immunity to regulate metabolic processes, such as occurs in lean and
obese adipose tissue. Such an architectural viewpoint allows unknown but putative functional modules to be predicted, such as in the regulation of hepatic
gluconeogenesis and thermogenesis.
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Reviewprostaglandins and leukotrienes, as well as intracellular media-
tors like calcium ions, kinases, or membrane depolarization)
capable of downstream action. This mediator can act locally or
distantly on one target or many; however, irrespective of specific
mechanism, it activates a downstream module to mount an
effector response. In contrast to that of the mediator response
initiated by the sensor, the direct purpose of the effector
response is elimination of the incident stimulus and the return
to the baseline condition of sterility.
The simplest and most familiar examples of this organization
are direct pathogen-clearance responses, as initially proposed
by Ruslan Medzhitov (Medzhitov, 2008). For example, recogni-
tion of bacteria-derived lipopolysaccharide (LPS) (stimulus) by
TLR4 (sensor) on a macrophage triggers activation of the inhib-
itor of kB kinase (IKK-b), mitogen-activated protein kinase
(MAPK), and interferon response factor 3 (IRF3) pathways (medi-
ator), which result in increased bactericidal activity (effector
response), thus enabling the cell to eliminate the LPS-producing
bacteria (original stimulus) (Figure 1). Although this discussion
treats component modules as singular entities—a single protein,
molecule, or chemical reaction—they comprise several to
many individual operations in most biological systems; forexample, bacterial lysis, although a single function, is a complex,
multistep process (Kawai and Akira, 2011). Similarly, feedback
mechanisms often comprise entire regulatory circuits in and of
themselves.
Such a modular architecture has profound functional implica-
tions. First, the use of discrete, independently functional mod-
ules allows a great diversity of processes to be constructed
from a relatively small number of components through combina-
torial variation. For example, a module that senses LPS can be
used to initiate a bactericidal effector response, as above, or it
can be used to drive production of cytokines, antigen presenta-
tion, or costimulation by coupling to different downstreammedi-
ator- or effector-response modules (Medzhitov et al., 1997).
Furthermore, the same effector response can be placed down-
stream of other sensor modules to create systems that react in
the same way to distinct stimuli (such as bactericidal responses
to TLR ligands other than LPS) (Kawai and Akira, 2011). Impor-
tantly, by deploying the same modules in multiple distinct
pathways (combinatorial diversity), modular organization allows
responses to be coordinated across multiple different systems,
enabling complex immunologic programs to be mounted and
coordinated with a relatively limited number of functionalImmunity 38, April 18, 2013 ª2013 Elsevier Inc. 645
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Reviewcomponents. As we saw above, TLR4 activation by a single
proinflammatory stimulus, LPS, activates a multitude of coordi-
nated downstream responses to facilitate clearance of the
offending bacterium (Medzhitov, 2008). Many of these are direct
effector functions (such as increased bactericidal activity in
phagocytes); however, others represent similarly organized but
distinct circuits nested within the larger response (e.g., cytokine
mediation of paracrine activation, chemokine recruitment of
additional effector leukocytes, and increased vascular perme-
ability to allow such an influx). As such, the presence of shared
modules enables disparate processes to be coordinated into a
coherent, effective whole.
Immunity and Metabolism
Modular organization is familiar to any immunologist—as we saw
above, the most well-studied host-defense responses are orga-
nized in this manner; however, these principles govern not only
immunity but also other biological processes. Indeed, evolution
has shaped mammals’ myriad regulatory networks along strik-
ingly similar lines, even to the extent of utilizing many of the
same functional modules across systems with disparate primor-
dial functions. Importantly, as modules shared within systems
coordinate system-wide responses, modules shared between
‘‘unrelated’’ systems represent key intersystem communication
nodes by cohering and coordinating all aspects of physiology
into functioning organisms. This interconnectivity is perhaps
best exemplified by the still-evolving intersection between
immunity and metabolism. Over the past 20 years, common
immune regulatory modules that have been located in many
metabolic pathways havemediated an immune axis of metabolic
control by operating in concert with themore canonical neuroen-
docrine, hormonal, and neural pathways (Hotamisligil, 2006;
Odegaard and Chawla, 2013; Qatanani and Lazar, 2007; Samuel
and Shulman, 2012). Moreover, common metabolic regulatory
modules have been reported in immune pathways, similarly
establishing metabolic influence over immune function (see the
accompanying review by Pearce and Pearce, 2013 in this issue
of Immunity). For example, diffusible and intracellular inflamma-
tory mediators (typified by tumor necrosis factor a [TNF-a] or
IL-1b and IKK-b or c-Jun BN-terminal kinase [JNK], respectively)
have now been shown to directly inhibit insulin signaling,
whereas direct nutrient recognition by immune sensor modules
(e.g., TLR4 and peroxisome-proliferator-activated receptor d
[PPARd] ligation by saturated and polyunsaturated fatty acids
[PUFAs], respectively) influences immune activation (Odegaard
et al., 2008; Pal et al., 2012). Indeed, despite the putative sepa-
ration in their primordial functions, immunity and metabolism
appear to be inextricably linked and coordinated by common
regulatory axes. In the sections that follow, we present examples
of how immunity participates in short-term metabolic responses
and integrates environmental inputs over time to effect long-term
metabolic adaptation in tissues.
White Adipose Tissue
Nowhere is immunity’s metabolic influence better understood
than in adipose tissue. Because white adipose tissue is the pri-
mary site ofmammalianenergy storage, its corephysiologic func-
tion isnutrient storageand release,bothofwhichareorchestrated
through the insulin signaling axis (Figure 2 and Box 1) (Rosen and646 Immunity 38, April 18, 2013 ª2013 Elsevier Inc.Spiegelman, 2006). In architectural terms, changes in serum
glucose concentration (stimulus) are sensed by the pancreatic
islet (sensor), where they are transduced to changes in insulin
secretion (mediator) (Figure 1). In the adipose tissue, insulin drives
uptakeandstorageofglucoseand fattyacidsand inhibits lipolysis
and fatty acid release (Rask-Madsen and Kahn, 2012). Overnutri-
tion, however, delivers nutrients in quantities beyond the capacity
of adipocytes to safely dispose, leading to varied manifestations
of cellular stress and dysfunction, including dysregulated lipid
balance (such as intracellular accumulation of diacylglycerols,
saturated fatty acids, and ceramides), mitochondrial dysfunction,
oxidative stress, and endoplasmic reticulum stress (Hotamisligil,
2010; Qatanani and Lazar, 2007). In turn, these diverse pro-
cesses, acting as surrogates for nutrient excess, activate a host
of intracellular signaling cascades that sense and communicate
adipocyte nutrient overload through the activation of JNK,
IKK-b, and protein kinase R (PKR) signaling pathways (Hirosumi
et al., 2002;Nakamuraet al., 2010;Yuanetal., 2001). In turn, these
signaling pathways directly antagonize the insulin signaling
pathway, primarily through inhibitory serine phosphorylation of
insulin receptor substrate (IRS) proteins (Aguirre et al., 2002;
Hotamisligil et al., 1996). Although this effect acutely inhibits
further nutrient uptake in an adipocyte-autonomous manner,
JNK and IKK-b activation also initiates a paracrine inflammatory
response involving cytokines, such as TNF-a and IL-1b, that
broadcast intracellular conditions toother adipocytesand, impor-
tantly, resident leukocytes in the immediate microenvironment
(OdegaardandChawla, 2013).Chronicactivationof this response
results in striking remodelingof adipose-tissue-associated leuko-
cyte populations with concomitant effects on systemic meta-
bolism and immune homeostasis.
Leukocyte influence over short-term metabolic changes in the
adipose tissue is largely unclear—adipocyte-autonomous
mechanisms seem dominant in this context. However, as dis-
cussed below, the collective data suggest that over longer
time frames, the immune microenvironment integrates environ-
mental inputs and accordingly adapts the metabolic baseline
to which more conventional metabolic responses are calibrated
by varying the number and phenotype of adipose tissue leuko-
cytes (Medzhitov, 2008; Odegaard and Chawla, 2012). Under
long-term conditions of healthy nutrient provision, for example,
the immune microenvironment adopts a regulatory phenotype
that actively maintains high adipocyte insulin sensitivity. Chronic
overnutrition, however, results in persistent cellular stress to
which the immune system responds by increasing the number
and inflammatory timbre of adipose tissue leukocytes to create
a new metabolic set point characterized by smoldering inflam-
mation and insulin resistance (Medzhitov, 2008; Odegaard and
Chawla, 2012). Importantly, once established, this new set point
represents the new baseline metabolic condition both systemat-
ically and within the adipose tissue and is defended by short-
term metabolic regulatory circuits even in the absence of
continued overnutrition, providing an immunological basis for
obesity’s tenacious resistance to weight loss.
Macrophages
As the most populous resident leukocyte in adipose tissue, the
macrophage is a central lineage through which overnutrition-
associated inflammatory signals act (Figure 1). In lean adipose
tissue, macrophages comprise 10% of total cellularity
Box 1. Energy Homeostasis
Although exceedingly complex in its specifics, whole-body
energy homeostasis functions itself as a metabolic circuit in
which nutrient need (stimulus), sensed as hunger, drives an
effector response of feeding behavior to replenish metabolic
stores (Figure 2A). The presence of nutrients in the gut lumen
triggers short-term regulatory feedback (satiety signals) that
inhibits acute feeding, whereas long-term patterns in feeding
are governed, in part, by leptin, a regulatory mediator pro-
duced in proportion to available nutrient stores (adipose tis-
sue). Once ingested, nutrients are apportioned via another
metabolic circuit in which rising glucose concentrations (stim-
ulus) trigger the b cells of the pancreas (sensor) to secrete in-
sulin (mediator), which, in turn, drives glucose uptake and
storage in skeletal muscle, liver, and fat (effector response)
and thus returns glucose concentrations to baseline. With
fasting (Figure 2B), glucose concentrations fall below base-
line, stimulating glucagon secretion, which mediates a variety
of catabolic responses. Skeletal muscle subsists on intracel-
lular stores of glycogen, whereas liver mobilizes its own stores
via glycogenolysis—supplemented by newly synthesized
glucose derived from gluconeogenesis—into circulation. Adi-
pose tissue similarly mobilizes its energy stores by releasing
fatty acids. These actions collectively raise circulating nutrient
concentrations and restore nutrient balance. The simplicity of
this schema is belied, of course, by the intricacy apparent on
closer inspection of any given component, each of which
comprises entire regulatory circuits. Furthermore, recurring
modules occupy key positions throughout these circuits (for
example, the insulin receptor is expressed on many different
metabolic tissues), forming the structural basis for the familiar
neuroendocrine, hormonal, and neural axes that coordinate
whole-body metabolism down to the level of single cells.
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Figure 2. Nutrient Handling in the Fed and Fasted States
(A) In fed mammals, the presence of nutrients in the gut lumen (stimulus) trig-
gers the production of satiety signals (mediator) that exert anorectic influences
on the brain to decrease feeding (effector response), thus limiting further
nutrient intake (feedback). As circulating nutrient concentrations rise (stimulus),
anabolic mediators, such as insulin, are released, which simultaneously drives
nutrient uptake and storage in peripheral tissues, such as skeletal muscle,
adipose tissue, and liver, and inhibits their release of stored nutrients. The net
result of this effector response is the decrease in circulating nutrient concen-
trations, which diminishes the incident stimulus for nutrient storage (feedback).
(B) In fasted mammals, nutrient levels fall below baseline (stimulus), triggering
catabolic mediators, such as glucagon, that drive mobilization of stored
nutrients into circulation while inhibiting their uptake (effector response),
replenishing circulating nutrient concentrations, and decreasing the incident
stimulus (feedback). These catabolic mediators also drive a parallel effector
response of increased hunger and thus feeding behavior, which eventually
similarly increases the circulating concentration of nutrients (feedback).
The following abbreviation is used: FAO, fatty-acid oxidation.
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Reviewand demonstrate an immunoregulatory phenotype (CD206+
CD301+ Arg1+ IL-10+) in response to tonic production of IL-4
by resident eosinophils and, to a lesser degree, IL-13 by resident
type 2 innate lymphoid (ILC2) cells (Lumeng et al., 2007;
Molofsky et al., 2013; Odegaard et al., 2007; Weisberg et al.,
2003; Wu et al., 2011) (Figure 3A). Although the incident stimulus
and sensor for this circuit are unknown, these macrophagesactively promote adipocyte insulin sensitivity (effector response),
most likely through the production of IL-10 and other mediators
(Kang et al., 2008; Lumeng et al., 2007; Odegaard et al., 2007).
Chronic overnutrition, however, stimulates intracellular stress
programs (sensor) within the adipocyte and activates similar
pathways within macrophages (Figure 3B). In these cells, high
concentrations of saturated fatty acids are sensed directly by
TLR4 and the bridging molecule fetuin-A (Pal et al., 2012) and,
via conversion to ceramides, indirectly through activation of
the nucleotide-binding domain, leucine-rich-containing family,
pyrin-domain-containing 3 (NLRP3) inflammasome, a central
nexus for IL-1b-mediated inflammation (Stienstra et al., 2010;
Vandanmagsar et al., 2011; Wen et al., 2011). These phlogistic
effector responses activate JNK and IKK-b pathways within
adipocytes to inhibit the insulin-sensitizing activity of alterna-
tively activated macrophages and skew the regulatory timbre
of the macrophage population within the adipose tissue. Impor-
tantly, these mediators include potent chemotactants, such as
chemokine C-C motif ligands 2 (CCL2), 5 (CCL5), and 8
(CCL8), that recruit large numbers of Ly6cHi monocytes, which
differentiate into tissue macrophages with a moderately inflam-
matory phenotype (CD11c+ NOS2+ TNF-a+) (Inouye et al.,
2007; Kamei et al., 2006; Kanda et al., 2006; WeisbergImmunity 38, April 18, 2013 ª2013 Elsevier Inc. 647
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Figure 3. Immune Regulation of Adipose Tissue Function
(A) In lean adipose tissue, ILC2-derived IL-5 supports the accumulation and maintenance of eosinophils, which alternatively activate resident macrophages via
IL-4 (also supported, in part, by ILC2-derived IL-13 and dietary factors such as PUFAs). In conjunction with Treg cells, alternatively activated macrophages
produce IL-10 and other mediators that directly promote adipocyte insulin sensitivity. Although ILC2 cells most likely occupy the sensor role in this context, the
stimulus and how it is sensed are unclear, as are the factors controlling Treg cell accumulation.
(B) Under conditions of chronic overnutrition, however, supraphysiologic nutrient concentrations activate intracellular stress signaling pathways with two primary
effects. First, these pathways directly inhibit insulin signaling in adipocytes, thus reducing uptake of additional nutrients into already stressed cells. Second, these
pathways trigger moderate inflammatory activation and accumulation of tissue-associated leukocytes that reinforce the inflammatory microenvironment, indi-
rectly further blunting insulin action. Both mediator paths lead to an end effector response of decreased adipocyte nutrient uptake, thus reducing intracellular
nutrient concentrations and decreasing the incident stimulus of nutrient overload.
Abbreviations are as follows: ATM, adipose tissue macrophage; SFA, saturated fatty acid; and IRS, insulin receptor substrate.
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Reviewet al., 2006). Although the inflammatory activity of these newly
recruited cells is substantially less than that observed in canon-
ical macrophage host-defense responses (Hotamisligil, 2006;
Medzhitov, 2008), their large number allows even their some-
what tepid inflammatory influence to overwhelm the pre-existing
regulatory macrophage population and thus skew the immune
microenvironment and drive macrophage representation to as
high as 50% of all nonadipocytes in obese adipose tissue (Weis-
berg et al., 2003; Xu et al., 2003). Importantly, abrogation of
either the recruitment or inflammatory activation of macro-
phages blunts overnutrition-associated dysfunction both sys-
tematically and in the adipose tissue, whereas contrapositive
interventions (such as impairment of alternative macrophage
activation or eosinophil depletion) have the opposite effect
(Odegaard and Chawla, 2013).
Mast Cells
Similar to macrophages, mast cells are also found in lean adi-
pose tissue and support the inflammatory transition associated648 Immunity 38, April 18, 2013 ª2013 Elsevier Inc.with chronic overnutrition (Figure 1), although the relative signif-
icance of their contribution is debated. Whereas studies using
KitW-sh/W-sh and KitWv/W animals are complicated by systemic
multilineage immune derangements, mast cell repletion (‘‘add-
back’’) models implicate mast-cell-derived IL-6 and interferon-
g (IFN-g) in obesity-related metabolic dysfunction (Liu et al.,
2009). Congruently, mast-cell-stabilizing therapeutics already
in clinical use (e.g., chromolyn and ketotifen) improve metabolic
function and promote weight loss in rodent models of diet-
induced obesity (Liu et al., 2009).
T Cells
Although macrophages form the numeric and functional bulk of
adipose tissue leukocytes, T lymphocytes play crucial roles in
regulating macrophage and adipocyte phenotypes alike. T
helper 2 (Th2) cells, type 1 (or invariant) natural killer T (iNKT) cells
(Ji et al., 2012; Lynch et al., 2012; Schipper et al., 2012), and reg-
ulatory T (Treg) cells are found in substantial numbers in lean
adipose tissue and participate in maintaining the tolerogenic
Immunity
Reviewimmune microenvironment through the production of type 2
cytokines, such as IL-4 and IL-10 (Feuerer et al., 2009) (Figures
1 and 3A). Indeed, RAG1-null mice (which lack T cells) demon-
strate impaired insulin signaling in adipocytes and, relative to
wild-type controls, increased susceptibility to weight gain, a
phenotype that is rescued by either Th2 or Treg cell repletion
(but not byCD8+ orCD4+ Th1Tcells) (Winer et al., 2009), whereas
depletion of Treg cells impairs adipocyte insulin signaling in
otherwise normal lean animals (Feuerer et al., 2009). Although
the mechanism is not currently known, this effect is possibly
mediated by participation in the ILC2-eosinophil-macrophage
regulatory immune axis described above (Figure 3A). With
chronic overnutrition, however, Th2-iNKT-Treg-cell dominance
is diluted by large numbers of CD8+, type 2 NKT (Nishimura
et al., 2009; Satoh et al., 2012), andTh1Tcells recruitedbyadipo-
cyte- and macrophage-derived chemokines (most notably
CCL20, RANTES, andCXCL12), skewing the overall T cell activa-
tion bias toward inflammatory responses that synergize with
those of the newly recruited macrophages (Winer et al., 2009)
(Figure 1). Aside from their influence on the inflammatory timbre
of the microenvironment, T cells also influence adipocytes
directly, possibly through the CD40-CD40L pathways, for
example (Poggi et al., 2011). Additionally, a recent report sug-
gests that adipocytes themselves are important antigen-pre-
senting cells that influence T cell activation in obesity; however,
the specific contribution of this pathway will require additional
verification using adipocyte-specific disruption of antigen pre-
sentation (Deng et al., 2013). Importantly, most adipose tissue
T cells, regardless of their specific lineage, demonstrate distinct
and limited T cell receptor repertoires relative to their circulating
counterparts, suggesting antigen-specific selection (although
the restriction mechanisms and cognate antigens are unknown).
B Cells
Although B cells (especially B2 cells) are found in lean adipose
tissue (Winer et al., 2011), no role for this lineage in normal tissue
homeostasis has yet been identified. In obese adipose tissue,
however, B cells increase in number, adopt an activated pheno-
type, and demonstrate immunoglobulin repertoire restriction
similar to that seen in the associated T cell receptor pool,
athough here, at least some of their cognate antigens are clearly
defined by the presence of pathogenic autoantibodies to intra-
cellular antigens such as Brutons kinase (BTK), glial fibrillary
acidic protein (GFAP), and golgi SNAP receptor complex mem-
ber 1 (GSOR1) (Winer et al., 2011). Aside from their role in auto-
antibody production, B cells in obese adipose tissue promote
CD8+ T cell responses, possibly through antigen presentation,
and thus exacerbate metabolic dysfunction in obesity (Figure 1).
Neutrophils
The same chemoattractant storm that recruits additional macro-
phages and lymphocytes also attracts other leukocytes that
normally eschew adipose tissue. Neutrophils, for example, are
largely absent from lean adipose tissue; however, they rapidly
infiltrate adipose tissue under conditions of nutrient excess
and have been reported to persist for months (Figure 1). Impor-
tantly, these neutrophils secrete elastase, a protease capable of
both blunting insulin signaling through IRS-1 degradation and
augmenting the inflammatory response through TLR4 signaling
pathways (Talukdar et al., 2012). Basophils, natural killer (NK)
cells, and other innate leukocytes have similarly been reportedto contribute to adipose tissue dysfunction in obesity; however,
the data for these lineages are scant and often controversial.
Liver
Whereas white adipose tissue serves as the primary long-term
energy repository in the body, the liver serves as the primary
short-term energy handling depot. As in the adipose tissue,
these functions are largely coordinated by the stimulus, sensor,
and mediator modules of the insulin signaling axis; however, the
effector functions of the liver also comprise the synthesis of both
lipids and glucose (gluconeogenesis), their short term storage
(glycogen), and their release (Figures 2A and 2B) (Lin and Accili,
2011). Although a great diversity of leukocytes are found within
the liver, relatively little is known of their contributions to these
routine hepatic functions. Despite this lack of knowledge, multi-
ple observations suggest a critical role for immune regulation of
routine hepatic function. The most convincing example of such
observations involves the liver’s resident macrophage popula-
tion (Kupffer cells). These cells comprise 10% of the liver’s
cellularity and demonstrate an immunoregulatory phenotype
similar to that observed in the adipose tissue. Although these
cells are critical in host defense and xenobiotic metabolism,
depletion of this lineage in healthy animals also disrupts hepatic
function in the absence of any toxic, infectious, or dietary
challenge and causes specific impairments in hepatocyte insulin
sensitivity and lipid metabolism (Huang et al., 2010; Papackova
et al., 2012). Importantly, this phenotype can be partially re-
capitulated through the selective ablation of Kupffer cell alterna-
tive activation via macrophage-specific PPARd deficiency (Kang
et al., 2008; Odegaard et al., 2008). Taken together, these data
suggest that alternatively activated Kupffer cells actively pro-
mote insulin sensitivity in the hepatocyte; however, as in the
adipose tissue, the mechanisms by which this effect is exerted
are unclear (although IL-10 is an attractive candidate). Moreover,
unlike in the adipose tissue, the upstream factors regulating tonic
macrophage activation have not yet been defined.
Whereas these data implicate a specific lineage (alternatively
activated macrophages) with unclear mediators, other data
implicate specific mediators but remain unclear regarding
specific lineages, sensors, stimuli, or other components of the
metabolic circuit. For example, a recent report has implicated
IL-13 in the hepatic response to feeding (Figure 1) (Stanya
et al., 2013). In the healthy liver, food intake is accompanied by
decreases in hepatic gluconeogenesis as systemic metabolism
shifts from catabolism to anabolism (Lin and Accili, 2011). This
inhibition had been thought to rely entirely on insulin (Figures
2A and 2B); however, Stanya et al. describe an immune-
mediated regulatory loop in which IL-13 (thought to be derived
from NKT cells) suppresses the hepatocyte gluconeogenic pro-
gram in response to food intake. Interestingly, IL-13 is reported
to mediate this effect by signaling through STAT3 in a non-
canonical signal-transduction pathway (Stanya et al., 2013).
Despite this intriguingmechanism, key components of thismeta-
bolic circuit—including the exact stimulus, sensor, and cell of
origin—are yet unknown, highlighting the spotty nature of the
current knowledge of immune contributions to healthy liver
function.
White adipose tissue’s striking hypertrophy and profound
functional changes have justifiably made it the most well-studiedImmunity 38, April 18, 2013 ª2013 Elsevier Inc. 649
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Reviewmanifestation of obesity-associated metabolic dysfunction;
however, the liver, as the central glucose- and lipid-handling
tissue, is acutely susceptible to nutrient toxicity as well. As in
the adipose tissue, nutrient excess in the liver leads to hepato-
cyte stress and activation of similar cell-autonomous signaling
modules shared between metabolic and immune pathways
(primarily IKK-b and JNK), which in the short term directly antag-
onize insulin signaling to prevent acute nutrient toxicity (Arkan
et al., 2005; Cai et al., 2005; Hirosumi et al., 2002). Unlike in
adipose tissue, however, long-term activation of these re-
sponses in the liver results in increased glucose production
rather than decreased glucose uptake (although insulin resis-
tance at both sites increases the release of fatty acids). This
effect, in turn, augments the accompanying peripheral insulin
resistance to raise serum concentrations of glucose.
Although the cell-autonomous responses to nutrient excess
are similar in both liver and fat, the liver-specific effects on
resident leukocyte populations are much less well described.
In both tissues, there is a general shift in the immune microen-
vironment from a regulatory bias to an inflammatory one;
however, the dramatic population-size changes typical in the
adipose tissue are not generally seen, perhaps because of the
liver’s more rigid tissue architecture. The tissue macrophage
population, for example, swaps an alternatively activated
phenotype for a more inflammatory bent (CD11c+ NOS2+
TNF-a+); however, unlike in the fat, this occurs without a signif-
icant increase in cell number (specifically, the most detailed
data suggest that a small decrease in resident macrophages
is offset by newly recruited cells) (Obstfeld et al., 2010).
Although the result is similar—inflammation antagonizes paren-
chymal insulin signaling both directly and via inhibition of
macrophage alternative activation programs—the mechanism
appears to involve either the phenotypic conversion of individ-
ual cells or their replacement, neither of which has been
described in the adipose tissue or liver. Importantly, this inflam-
matory switch in macrophage phenotype is mechanistically
crucial despite the absence of marked numerical changes as
either genetic abrogation of macrophage inflammatory signaling
(Arkan et al., 2005) or wholesale lineage depletion dramatically
reduces the overnutrition-associated phenotype (Huang et al.,
2010; Papackova et al., 2012). In obesity, other liver resident
leukocyte populations undergo similar, isometric inflammatory
activation that, to varying degrees, supports metabolic dysfunc-
tion; however, whether this is due to primary, liver-specific pro-
cesses or to systemic inflammation is unclear. As in the adipose
tissue, neutrophils are not known to contribute to the resident
leukocyte population of the healthy liver; however, they are re-
cruited to chronically overfed livers, where they contribute to
metabolic dysfunction through augmentation of TLR4 signaling
and direct degradation of IRS-1 within hepatocytes (Talukdar
et al., 2012).
As in the adipose tissue, liver-specific immune responses
integrate long-term environmental conditions and accordingly
adjust the metabolic baseline state, promoting insulin sensitivity
under conditions of metabolic normalcy. The immune response
to chronic overnutrition, in contrast, alters the leukocyte land-
scape to promote insulin resistance, stemming the nutrient
influx into already stressed hepatocytes. This new metabolic
set point is furthermore stable in that it is protected by short-650 Immunity 38, April 18, 2013 ª2013 Elsevier Inc.term metabolic regulatory circuits as the new homeostatic
baseline.
Brown Adipose Tissue
Although the majority of the work on immunity-metabolism inter-
actions has focused on glucose homeostasis (and thus on white
adipose tissue, liver, and skeletal muscle), temperature regula-
tion is another important area in which immune metabolic
regulation has been shown to play a key role. In mammals,
thermoregulation is composed of both heat-loss-reducing stra-
tegies (such as piloerection and cold-aversion behavior) and
heat-generating strategies, of which nonshivering thermogen-
esis is the most important (Cannon and Nedergaard, 2011;
Lowell and Spiegelman, 2000; Tseng et al., 2010). In this
response, cold exposure (stimulus) triggers an increase in sym-
pathetic nervous system tone (mediator), which instructs brown
adipocytes to dramatically increase uncoupled fatty acid oxida-
tion, liberating large amounts of heat (effector response). Until
recently, this response was thought to be mediated entirely by
direct sympathetic innervation of brown adipocytes; however,
recent work has demonstrated an unexpected requirement for
alternatively activated adipose tissue macrophages. Interest-
ingly, these cells not only form a critical component of the
sympathetic efferent limb, accounting for50%of secreted cat-
echolamines, but also comprise a second, integrated metabolic
circuit in which the fatty acids necessary to fuel thermogenesis
are mobilized from the adjacent white adipose tissue (Nguyen
et al., 2011). Congruently, the acute thermogenic response is
markedly blunted in both amplitude and duration in animals
with impairedmacrophage IL-4 and IL-13 signaling. Despite their
common requirement for macrophage alternative activation,
however, cold exposure and the basal nutrient-handling cues
discussed above activate distinct effector modules within these
cells. IL-10, for example, has not been implicated in the thermo-
genic response, and catecholamine production is similarly unin-
volved in the maintenance of adipocyte insulin sensitivity.
In parallel with its role in short-term regulation of body
temperature, the macrophage-adrenergic axis might also partic-
ipate inmetabolic adaptation to long-term temperature changes.
Long-standing observations have demonstrated that chronic
exposure to cold or b3-activating adrenergic agents results in
increased brown adipose tissue mass both through hyperplasia
of existing brown adipocytes and through acquisition of
thermogenic capacity (‘‘browning’’) by existing white adipocytes
(Frontini and Cinti, 2010; Lee et al., 2012). From an architectural
perspective, mediators derived from short-term response acti-
vation are ideally positioned to further mediate these long-term
adaptations as well. For example, macrophage-dependent
adrenergic signaling might activate long-term adaptations in
white adipose tissue in addition to short-term thermogenic
responses, possibly via fibroblast growth factor 21 signaling,
which was recently implicated in cold-induced browning of white
adipocytes (Fisher et al., 2012).
Although parkas and central heating might have decreased
thermogenesis’s primeval evolutionary imperative, the structure
and regulation of thermogenic responses have never been more
hotly pursued as a result of their therapeutic potential in the cur-
rent obesity epidemic (Tseng et al., 2010). In this context, brown
adipose tissue, with its remarkable capacity to burn fat, is seen
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excess calories will simply burn away. Although only speculative
at this point, a great deal of evidence, including the therapeutic
success of transplantation, pharmacologic activation, and
genetic augmentation of brown adipose tissue in mice, supports
this approach (Wu et al., 2013). Importantly, however, the depen-
dence of thermogenesis on IL-4 signaling and alternative macro-
phage activation raises important questions about how it is
affected by obesity’s inflammatory influence, especially in the
context of the anatomic and functional overlap between brown
and white adipose tissues.
Central Metabolic Regulation in the Hypothalamus
Metabolic regulation, as seen in the examples above, is often
as much the adaptation to behavioral variation as that to
environmental variation. Bridging this divide, central metabolic
regulation is an intriguing aspect of metabolic study in which
researchers have begun to describe immune networks with
more long-lasting implications for central metabolism, most
notably in the context of energy balance and feeding behavior.
Indeed, despite strikingly divergent phenotypes, cachexia
(a wasting syndrome associated with chronic inflammatory
conditions, such as cancer) and obesity-related metabolic dis-
ease have now both been causally linked to activation of the
same inflammatory signaling pathways in the hypothalamus.
In cachexia, chronic production of proinflammatory mediators,
such as TNF-a and IL-1b, activates JNK and IKK-b signaling
in proopiomelanocortin (POMC)-expressing neurons in the
medial basal hypothalamus, triggering the classic pairing of
anorexia and increased energy expenditure as an effector
response (Cai and Liu, 2011). Although the long-term conse-
quence of this new metabolic baseline (wasting) is undoubtedly
maladaptive, decreased appetite might function adaptively in
the short term to decrease further exposure to ingested patho-
gens, whereas increased basal metabolic rate might augment
host-defense responses (Medzhitov, 2008). Interestingly, sus-
tained moderate elevation of the same inflammatory mediators,
as occurs during overnutrition, activates the same sig-
naling pathways in both agouti-related peptide- and POMC-
expressing arcuate neurons with opposite effects—food intake
is increased, whereas whole-body energy expenditure is
decreased (Belgardt et al., 2010; Purkayastha et al., 2011;
Sabio et al., 2010; Zhang et al., 2008). As in the cachectic
response, long-term activation here establishes a new, appar-
ently detrimental baseline condition that promotes persistence
and exacerbation of metabolic dysfunction. The putative adap-
tive functions served by short-term activation are unclear but
might include activation of downstream effectors to mitigate
cellular stress.
Although these processes regulate metabolic responses
(basal metabolic rate and appetite) through immune mediators
(inflammatory cytokines and signaling pathways), little is known
about the contributions of individual leukocyte lineages to this
process. Certainly their aggregate effects in the periphery are
important; however, the hypothalamus comprises resident and
transient leukocyte populations (such as microglia and lympho-
cytes, respectively) similar to those of other tissues. The com-
plete relevance of each of these cells is not yet clear; however,
IKK-b-mediated microglial activation, for example, has beenimplicated in overnutrition-associated neuron and neural stem
cell damage (Li et al., 2012).
Conclusion
Immunity andmetabolism have coevolved throughmillennia with
a common architectural organization and common, vital biolog-
ical goals (Afacan et al., 2012). Given these commonalities and
their extended cohabitation, it is not surprising that immunity
and metabolism have become entangled and have instructed
and coordinated their activities through common regulatory
axes such that host defense and metabolic provision are
mutually maintained. Considering this, functional models that
integrate immunity and metabolism into a common architectural
organization have fundamentally changed our understanding of
both disciplines. Similarly, our grasp of immune phenomena as
basic as macrophage activation has been reshaped by the
inclusion of metabolism (Cramer et al., 2003; Vats et al., 2006).
Moreover, the intrinsic regularity of the architectural context itself
highlights the gaps remaining in our understanding. Although
examples of this can be found in the original hypotheses behind
many of today’s facts, current models still expose vacancies. For
example, functional models in brown adipose tissue explain
short-term thermogenic responses and describe similarly
directed long-term adaptations; however, themechanism linking
the two remains unclear. Applying architectural observations
from other metabolic systems suggests that short-term thermo-
regulatory responses should connect in some way to long-term
mechanisms; however, none have yet been described. Similarly,
IL-13, an immunemediator, has been assigned an important role
in regulating gluconeogenesis; however, the exact stimulus and
sensor modules are unknown.
Despite its importance, the identification of individual regula-
tory circuit components is only the prelude to applying those
functional models to practical, real-world gain. Most poignantly,
overnutrition-associated metabolic dysfunction is sweeping
both the developed and developing worlds with epidemics
of diabetes, cardiovascular disease, cancer, and other end-
pathology confederates (Adams et al., 2006; Finucane et al.,
2011). Although in their infancy, efforts to understand this
pathology in a way that integrates metabolism and immunity
have already led to the identification of salicylates (e.g., salsa-
late), direct cytokine antagonists (e.g., canakinumab, infliximab,
entanercept), leukocyte-depleting agents (e.g., CD3- and CD20-
targeting antibodies), and other immunomodulators (e.g.,
amlexanox, resolvins) as potential treatments for metabolic
disease (Brooks-Worrell et al., 2012; Reilly et al., 2013). More-
over, metabolic agents (e.g., PUFAs, AMP-activated protein
kinase agonists, PPAR agonists, DPP-4 inhibitors) also show
promise as novel immunomodulatory interventions (O’Neill and
Hardie, 2013).
The recent progress reviewed above establishes immunity as
a bona fide metabolic regulatory axis and opens exciting new
therapeutic avenues; however, immune influence over many
metabolic processes and tissues remains unclear. How does
immunity participate in metabolic homeostasis in the pancreatic
islet? In the gut? In themuscle? How does it participate in fasting
responses in weight loss or in times of stress? How are these
effects modulated by interaction with traditional and other
nontraditional metabolic axes? In each of these cases, thereImmunity 38, April 18, 2013 ª2013 Elsevier Inc. 651
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Reviewexists evidence to suggest immune participation; however,
important questions remain outstanding, and the answers to
these questions promise to increase our understanding of
immunity, metabolism, and their joint dysfunction and to bolster
our ability to therapeutically intervene therein.
ACKNOWLEDGMENTS
We thank L. Mukundan for constructive comments on this manuscript.
A.C. was supported by grants from the NIH (HL076746, DK094641), Larry
L. Hillblom Foundation Network, and Diabetes Family Fund (UCSF) and by
an AHA Innovative Award (12PILT11840038) and an NIH Director’s Pioneer
Award (DP1AR064158).
REFERENCES
Adams, K.F., Schatzkin, A., Harris, T.B., Kipnis, V., Mouw, T., Ballard-Barbash,
R., Hollenbeck, A., and Leitzmann, M.F. (2006). Overweight, obesity, and
mortality in a large prospective cohort of persons 50 to 71 years old.
N. Engl. J. Med. 355, 763–778.
Afacan, N.J., Fjell, C.D., and Hancock, R.E. (2012). A systems biology
approach to nutritional immunology - focus on innate immunity. Mol. Aspects
Med. 33, 14–25.
Aguirre, V., Werner, E.D., Giraud, J., Lee, Y.H., Shoelson, S.E., andWhite, M.F.
(2002). Phosphorylation of Ser307 in insulin receptor substrate-1 blocks
interactions with the insulin receptor and inhibits insulin action. J. Biol.
Chem. 277, 1531–1537.
Arkan, M.C., Hevener, A.L., Greten, F.R., Maeda, S., Li, Z.W., Long, J.M.,
Wynshaw-Boris, A., Poli, G., Olefsky, J., and Karin, M. (2005). IKK-beta links
inflammation to obesity-induced insulin resistance. Nat. Med. 11, 191–198.
Belgardt, B.F., Mauer, J., Wunderlich, F.T., Ernst, M.B., Pal, M., Spohn, G.,
Bro¨nneke, H.S., Brodesser, S., Hampel, B., Schauss, A.C., and Bru¨ning,
J.C. (2010). Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling
coordinately regulates glucose metabolism. Proc. Natl. Acad. Sci. USA 107,
6028–6033.
Boehm, T. (2012). Evolution of vertebrate immunity. Curr. Biol. 22, R722–R732.
Brooks-Worrell, B., Narla, R., and Palmer, J.P. (2012). Biomarkers and
immune-modulating therapies for type 2 diabetes. Trends Immunol. 33,
546–553.
Cai, D., and Liu, T. (2011). Hypothalamic inflammation: a double-edged sword
to nutritional diseases. Ann. N Y Acad. Sci. 1243, E1–E39.
Cai, D., Yuan, M., Frantz, D.F., Melendez, P.A., Hansen, L., Lee, J., and
Shoelson, S.E. (2005). Local and systemic insulin resistance resulting from
hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11, 183–190.
Cannon, B., and Nedergaard, J. (2011). Nonshivering thermogenesis and its
adequate measurement in metabolic studies. J. Exp. Biol. 214, 242–253.
Cramer, T., Yamanishi, Y., Clausen, B.E., Fo¨rster, I., Pawlinski, R., Mackman,
N., Haase, V.H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003). HIF-1alpha is
essential for myeloid cell-mediated inflammation. Cell 112, 645–657.
Deng, T., Lyon, C.J., Minze, L.J., Lin, J., Zou, J., Liu, J.Z., Ren, Y., Yin, Z.,
Hamilton, D.J., Reardon, P.R., et al. (2013). Class II Major Histocompatibility
Complex Plays an Essential Role in Obesity-Induced Adipose Inflammation.
Cell Metab. 17, 411–422.
Elinav, E., Strowig, T., Henao-Mejia, J., and Flavell, R.A. (2011). Regulation of
the antimicrobial response by NLR proteins. Immunity 34, 665–679.
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J.,
Goldfine, A.B., Benoist, C., Shoelson, S., and Mathis, D. (2009). Lean, but
not obese, fat is enriched for a unique population of regulatory T cells that
affect metabolic parameters. Nat. Med. 15, 930–939.
Finucane, M.M., Stevens, G.A., Cowan, M.J., Danaei, G., Lin, J.K., Paciorek,
C.J., Singh, G.M., Gutierrez, H.R., Lu, Y., Bahalim, A.N., et al.; Global Burden
of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body
Mass Index). (2011). National, regional, and global trends in body-mass index
since 1980: systematic analysis of health examination surveys and epidemio-652 Immunity 38, April 18, 2013 ª2013 Elsevier Inc.logical studies with 960 country-years and 9$1million participants. Lancet 377,
557–567.
Fisher, F.M., Kleiner, S., Douris, N., Fox, E.C., Mepani, R.J., Verdeguer, F., Wu,
J., Kharitonenkov, A., Flier, J.S., Maratos-Flier, E., and Spiegelman, B.M.
(2012). FGF21 regulates PGC-1a and browning of white adipose tissues in
adaptive thermogenesis. Genes Dev. 26, 271–281.
Frontini, A., and Cinti, S. (2010). Distribution and development of brown
adipocytes in the murine and human adipose organ. Cell Metab. 11, 253–256.
Hirosumi, J., Tuncman, G., Chang, L., Go¨rgu¨n, C.Z., Uysal, K.T., Maeda, K.,
Karin, M., and Hotamisligil, G.S. (2002). A central role for JNK in obesity and
insulin resistance. Nature 420, 333–336.
Hotamisligil, G.S. (2006). Inflammation and metabolic disorders. Nature 444,
860–867.
Hotamisligil, G.S. (2010). Endoplasmic reticulum stress and the inflammatory
basis of metabolic disease. Cell 140, 900–917.
Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F., and Spiegel-
man, B.M. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase
activity in TNF-alpha- and obesity-induced insulin resistance. Science 271,
665–668.
Huang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J.J.,
Scott, D.K., and O’Doherty, R.M. (2010). Depletion of liver Kupffer cells
prevents the development of diet-induced hepatic steatosis and insulin
resistance. Diabetes 59, 347–357.
Humphries, M.M., Thomas, D.W., and Kramer, D.L. (2003). The role of energy
availability in Mammalian hibernation: a cost-benefit approach. Physiol.
Biochem. Zool. 76, 165–179.
Inouye, K.E., Shi, H., Howard, J.K., Daly, C.H., Lord, G.M., Rollins, B.J., and
Flier, J.S. (2007). Absence of CC chemokine ligand 2 does not limit obesity-
associated infiltration of macrophages into adipose tissue. Diabetes 56,
2242–2250.
Ji, Y., Sun, S., Xu, A., Bhargava, P., Yang, L., Lam, K.S., Gao, B., Lee, C.H.,
Kersten, S., and Qi, L. (2012). Activation of natural killer T cells promotes M2
Macrophage polarization in adipose tissue and improves systemic glucose
tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity.
J. Biol. Chem. 287, 13561–13571.
Kamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N.,
Ohtsuka-Kowatari, N., Kumagai, K., Sakamoto, K., Kobayashi, M., et al.
(2006). Overexpression of monocyte chemoattractant protein-1 in adipose
tissues causes macrophage recruitment and insulin resistance. J. Biol.
Chem. 281, 26602–26614.
Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., Kitazawa,
S., Miyachi, H., Maeda, S., Egashira, K., and Kasuga, M. (2006). MCP-1 con-
tributes to macrophage infiltration into adipose tissue, insulin resistance, and
hepatic steatosis in obesity. J. Clin. Invest. 116, 1494–1505.
Kang, K., Reilly, S.M., Karabacak, V., Gangl, M.R., Fitzgerald, K., Hatano, B.,
and Lee, C.H. (2008). Adipocyte-derived Th2 cytokines and myeloid
PPARdelta regulate macrophage polarization and insulin sensitivity. Cell
Metab. 7, 485–495.
Kawai, T., and Akira, S. (2011). Toll-like receptors and their crosstalk with other
innate receptors in infection and immunity. Immunity 34, 637–650.
Lamkanfi, M., and Dixit, V.M. (2012). Inflammasomes and their roles in health
and disease. Annu. Rev. Cell Dev. Biol. 28, 137–161.
Lee, Y.H., Petkova, A.P., Mottillo, E.P., and Granneman, J.G. (2012).
In vivo identification of bipotential adipocyte progenitors recruited by b3-adre-
noceptor activation and high-fat feeding. Cell Metab. 15, 480–491.
Li, J., Tang, Y., and Cai, D. (2012). IKKb/NF-kB disrupts adult hypothalamic
neural stem cells to mediate a neurodegenerative mechanism of dietary
obesity and pre-diabetes. Nat. Cell Biol. 14, 999–1012.
Lin, H.V., and Accili, D. (2011). Hormonal regulation of hepatic glucose produc-
tion in health and disease. Cell Metab. 14, 9–19.
Liu, J., Divoux, A., Sun, J., Zhang, J., Cle´ment, K., Glickman, J.N., Sukhova,
G.K., Wolters, P.J., Du, J., Gorgun, C.Z., et al. (2009). Genetic deficiency
and pharmacological stabilization of mast cells reduce diet-induced obesity
and diabetes in mice. Nat. Med. 15, 940–945.
Immunity
ReviewLowell, B.B., and Spiegelman, B.M. (2000). Towards a molecular under-
standing of adaptive thermogenesis. Nature 404, 652–660.
Lumeng, C.N., Bodzin, J.L., and Saltiel, A.R. (2007). Obesity induces a
phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest.
117, 175–184.
Lynch, L., Nowak, M., Varghese, B., Clark, J., Hogan, A.E., Toxavidis, V., Balk,
S.P., O’Shea, D., O’Farrelly, C., and Exley, M.A. (2012). Adipose tissue
invariant NKT cells protect against diet-induced obesity and metabolic
disorder through regulatory cytokine production. Immunity 37, 574–587.
Medzhitov, R. (2008). Origin and physiological roles of inflammation. Nature
454, 428–435.
Medzhitov, R., Preston-Hurlburt, P., and Janeway, C.A., Jr. (1997). A human
homologue of the Drosophila Toll protein signals activation of adaptive
immunity. Nature 388, 394–397.
Molofsky, A.B., Nussbaum, J.C., Liang, H.E., Van Dyken, S.J., Cheng, L.E.,
Mohapatra, A., Chawla, A., and Locksley, R.M. (2013). Innate lymphoid type
2 cells sustain visceral adipose tissue eosinophils and alternatively activated
macrophages. J. Exp. Med. 210, 535–549.
Nakamura, T., Furuhashi, M., Li, P., Cao, H., Tuncman, G., Sonenberg, N.,
Gorgun, C.Z., and Hotamisligil, G.S. (2010). Double-stranded RNA-dependent
protein kinase links pathogen sensing with stress and metabolic homeostasis.
Cell 140, 338–348.
Nguyen, K.D., Qiu, Y., Cui, X., Goh, Y.P., Mwangi, J., David, T., Mukundan, L.,
Brombacher, F., Locksley, R.M., and Chawla, A. (2011). Alternatively activated
macrophages produce catecholamines to sustain adaptive thermogenesis.
Nature 480, 104–108.
Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M.,
Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009). CD8+ effector T cells
contribute to macrophage recruitment and adipose tissue inflammation in
obesity. Nat. Med. 15, 914–920.
O’Neill, L.A., and Hardie, D.G. (2013). Metabolism of inflammation limited by
AMPK and pseudo-starvation. Nature 493, 346–355.
Obstfeld, A.E., Sugaru, E., Thearle, M., Francisco, A.M., Gayet, C., Ginsberg,
H.N., Ables, E.V., and Ferrante, A.W., Jr. (2010). C-C chemokine receptor 2
(CCR2) regulates the hepatic recruitment of myeloid cells that promote
obesity-induced hepatic steatosis. Diabetes 59, 916–925.
Odegaard, J.I., and Chawla, A. (2012). Leukocyte set points in metabolic
disease. F1000 Biol Rep 4, 13.
Odegaard, J.I., and Chawla, A. (2013). Pleiotropic actions of insulin resistance
and inflammation in metabolic homeostasis. Science 339, 172–177.
Odegaard, J.I., Ricardo-Gonzalez, R.R., Goforth, M.H., Morel, C.R.,
Subramanian, V., Mukundan, L., Red Eagle, A., Vats, D., Brombacher, F.,
Ferrante, A.W., and Chawla, A. (2007). Macrophage-specific PPARgamma
controls alternative activation and improves insulin resistance. Nature 447,
1116–1120.
Odegaard, J.I., Ricardo-Gonzalez, R.R., Red Eagle, A., Vats, D., Morel, C.R.,
Goforth, M.H., Subramanian, V., Mukundan, L., Ferrante, A.W., and Chawla,
A. (2008). Alternative M2 activation of Kupffer cells by PPARdelta ameliorates
obesity-induced insulin resistance. Cell Metab. 7, 496–507.
Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray,
S., Majumdar, S.S., and Bhattacharya, S. (2012). Fetuin-A acts as an endoge-
nous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med.
Published online July, 29, 2012. http://dx.doi.org/10.1038/nm.2851.
Papackova, Z., Palenickova, E., Dankova, H., Zdychova, J., Skop, V.,
Kazdova, L., and Cahova, M. (2012). Kupffer cells ameliorate hepatic insulin
resistance induced by high-fat diet rich in monounsaturated fatty acids: the
evidence for the involvement of alternatively activated macrophages. Nutr.
Metab. (Lond) 9, 22.
Pearce, E.L., and Pearce, E.J. (2013). Metabolic Pathways in Immune Cell
Activation and Quiescence. Immunity 38, this issue, 633–643.
Poggi, M., Engel, D., Christ, A., Beckers, L., Wijnands, E., Boon, L., Driessen,
A., Cleutjens, J., Weber, C., Gerdes, N., and Lutgens, E. (2011). CD40L
deficiency ameliorates adipose tissue inflammation and metabolic manifesta-
tions of obesity in mice. Arterioscler. Thromb. Vasc. Biol. 31, 2251–2260.Purkayastha, S., Zhang, G., and Cai, D. (2011). Uncoupling the mechanisms of
obesity and hypertension by targeting hypothalamic IKK-b and NF-kB. Nat.
Med. 17, 883–887.
Qatanani, M., and Lazar, M.A. (2007). Mechanisms of obesity-associated
insulin resistance: many choices on the menu. Genes Dev. 21, 1443–1455.
Rask-Madsen, C., and Kahn, C.R. (2012). Tissue-specific insulin signaling,
metabolic syndrome, and cardiovascular disease. Arterioscler. Thromb.
Vasc. Biol. 32, 2052–2059.
Reilly, S.M., Chiang, S.H., Decker, S.J., Chang, L., Uhm, M., Larsen, M.J.,
Rubin, J.R., Mowers, J., White, N.M., Hochberg, I., et al. (2013). An inhibitor
of the protein kinases TBK1 and IKK-e improves obesity-related metabolic
dysfunctions in mice. Nat. Med. 19, 313–321.
Rosen, E.D., and Spiegelman, B.M. (2006). Adipocytes as regulators of energy
balance and glucose homeostasis. Nature 444, 847–853.
Sabio, G., Cavanagh-Kyros, J., Barrett, T., Jung, D.Y., Ko, H.J., Ong, H.,Morel,
C., Mora, A., Reilly, J., Kim, J.K., and Davis, R.J. (2010). Role of the
hypothalamic-pituitary-thyroid axis in metabolic regulation by JNK1. Genes
Dev. 24, 256–264.
Samuel, V.T., and Shulman, G.I. (2012). Mechanisms for insulin resistance:
common threads and missing links. Cell 148, 852–871.
Satoh, M., Andoh, Y., Clingan, C.S., Ogura, H., Fujii, S., Eshima, K., Nakayama,
T., Taniguchi, M., Hirata, N., Ishimori, N., et al. (2012). Type II NKT cells
stimulate diet-induced obesity by mediating adipose tissue inflammation,
steatohepatitis and insulin resistance. PLoS ONE 7, e30568.
Schipper, H.S., Rakhshandehroo, M., van de Graaf, S.F., Venken, K., Koppen,
A., Stienstra, R., Prop, S., Meerding, J., Hamers, N., Besra, G., et al. (2012).
Natural killer T cells in adipose tissue prevent insulin resistance. J. Clin. Invest.
122, 3343–3354.
Stanya, K.J., Jacobi, D., Liu, S., Bhargava, P., Dai, L., Gangl, M.R., Inouye, K.,
Barlow, J.L., Ji, Y., Mizgerd, J.P., et al. (2013). Direct control of hepatic glucose
production by interleukin-13 in mice. J. Clin. Invest. 123, 261–271.
Stienstra, R., Joosten, L.A., Koenen, T., van Tits, B., van Diepen, J.A., van den
Berg, S.A., Rensen, P.C., Voshol, P.J., Fantuzzi, G., Hijmans, A., et al. (2010).
The inflammasome-mediated caspase-1 activation controls adipocyte differ-
entiation and insulin sensitivity. Cell Metab. 12, 593–605.
Talukdar, S., Oh, Y., Bandyopadhyay, G., Li, D., Xu, J., McNelis, J., Lu, M., Li,
P., Yan, Q., Zhu, Y., et al. (2012). Neutrophils mediate insulin resistance inmice
fed a high-fat diet through secreted elastase. Nat. Med. 18, 1407–1412.
Tseng, Y.H., Cypess, A.M., and Kahn, C.R. (2010). Cellular bioenergetics as a
target for obesity therapy. Nat. Rev. Drug Discov. 9, 465–482.
Vandanmagsar, B., Youm, Y.H., Ravussin, A., Galgani, J.E., Stadler, K.,
Mynatt, R.L., Ravussin, E., Stephens, J.M., and Dixit, V.D. (2011). The
NLRP3 inflammasome instigates obesity-induced inflammation and insulin
resistance. Nat. Med. 17, 179–188.
Vats, D., Mukundan, L., Odegaard, J.I., Zhang, L., Smith, K.L., Morel, C.R.,
Wagner, R.A., Greaves, D.R., Murray, P.J., and Chawla, A. (2006). Oxidative
metabolism and PGC-1beta attenuate macrophage-mediated inflammation.
Cell Metab. 4, 13–24.
Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., and
Ferrante, A.W., Jr. (2003). Obesity is associated with macrophage accumula-
tion in adipose tissue. J. Clin. Invest. 112, 1796–1808.
Weisberg, S.P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K.,
Charo, I., Leibel, R.L., and Ferrante, A.W., Jr. (2006). CCR2 modulates
inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116,
115–124.
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M.T., Brickey, W.J., and
Ting, J.P. (2011). Fatty acid-induced NLRP3-ASC inflammasome activation
interferes with insulin signaling. Nat. Immunol. 12, 408–415.
Wilson, G.P., Evans, A.R., Corfe, I.J., Smits, P.D., Fortelius, M., and Jernvall, J.
(2012). Adaptive radiation of multituberculate mammals before the extinction
of dinosaurs. Nature 483, 457–460.
Winer, S., Chan, Y., Paltser, G., Truong, D., Tsui, H., Bahrami, J., Dorfman, R.,
Wang, Y., Zielenski, J., Mastronardi, F., et al. (2009). Normalization of obesity-
associated insulin resistance through immunotherapy. Nat. Med. 15, 921–929.Immunity 38, April 18, 2013 ª2013 Elsevier Inc. 653
Immunity
ReviewWiner, D.A., Winer, S., Shen, L., Wadia, P.P., Yantha, J., Paltser, G., Tsui, H.,
Wu, P., Davidson, M.G., Alonso, M.N., et al. (2011). B cells promote insulin
resistance through modulation of T cells and production of pathogenic IgG
antibodies. Nat. Med. 17, 610–617.
Wu, D., Molofsky, A.B., Liang, H.E., Ricardo-Gonzalez, R.R., Jouihan, H.A.,
Bando, J.K., Chawla, A., and Locksley, R.M. (2011). Eosinophils sustain
adipose alternatively activated macrophages associated with glucose homeo-
stasis. Science 332, 243–247.
Wu, J., Cohen, P., and Spiegelman, B.M. (2013). Adaptive thermogenesis in
adipocytes: is beige the new brown? Genes Dev. 27, 234–250.654 Immunity 38, April 18, 2013 ª2013 Elsevier Inc.Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols,
A., Ross, J.S., Tartaglia, L.A., and Chen, H. (2003). Chronic inflammation in fat
plays a crucial role in the development of obesity-related insulin resistance.
J. Clin. Invest. 112, 1821–1830.
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.W., Karin, M., and
Shoelson, S.E. (2001). Reversal of obesity- and diet-induced insulin resistance
with salicylates or targeted disruption of Ikkbeta. Science 293, 1673–1677.
Zhang, X., Zhang, G., Zhang, H., Karin, M., Bai, H., and Cai, D. (2008).
Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy
imbalance and obesity. Cell 135, 61–73.
